Research Article
Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece
Table 3
Association of basic patient and tumor characteristics with first-line chemotherapy regimen.
| Characteristics | Chemotherapy regimen | Nab-paclitaxel-gemcitabine | FOLFIRINOX/CAPOXIRI | Gemcitabine | Others | value |
| Age (years) | <70 | N (%) | 70 | 36 | 7 | 18 | 0.003 | 61.9 | 85.7 | 43.8 | 81.8 | | ≥70 | N (%) | 43 | 6 | 9 | 4 | | 38.1 | 14.3 | 56.2 | 18.2 | | Sex | Male | N (%) | 59 | 26 | 6 | 14 | 0.287 | 52.2 | 61.9 | 37.5 | 63.6 | | Female | N (%) | 54 | 16 | 10 | 8 | | 47.8 | 38.1 | 62.5 | 36.4 | | ECOG PS | 0 | N (%) | 49 | 22 | 1 | 12 | <0.001 | 55.0 | 62.9 | 8.3 | 70.6 | | 1 | N (%) | 37 | 12 | 5 | 4 | | 41.6 | 34.2 | 41.7 | 23.5 | | 2-3 | N (%) | 3 | 1 | 6 | 1 | | 3.4 | 2.9 | 50.0 | 5.9 | | Tumor stage | III | N (%) | 15 | 4 | 4 | 1 | 0.010 | 13.5 | 10.0 | 25.0 | 4.5 | | IV | N (%) | 74 | 19 | 12 | 13 | | 66.7 | 47.5 | 75.0 | 59.1 | | Relapse | N (%) | 22 | 17 | 0 | 8 | | 19.8 | 42.5 | 0.0 | 36.4 | | Total | N (%) | 111 | 40 | 16 | 22 | | | 100.0% | 100.0 | 100.0 | 100.0 | | |
|
|